Latest Insider Transactions at Accenture PLC (ACN)
This section provides a real-time view of insider transactions for Accenture PLC (ACN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Accenture plc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Accenture plc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 05
2020
|
Simon Eaves Group Chief Executive-Products |
BUY
Grant, award, or other acquisition
|
Direct |
114
+1.2%
|
$24,168
$212.44 P/Share
|
|
Feb 05
2020
|
James O Etheredge Chief Exec-North America |
BUY
Grant, award, or other acquisition
|
Direct |
114
+0.85%
|
$24,168
$212.44 P/Share
|
|
Feb 05
2020
|
James O Etheredge Chief Exec-North America |
SELL
Open market or private sale
|
Direct |
1,274
-2.26%
|
$270,088
$212.32 P/Share
|
|
Feb 05
2020
|
Kathleen R Mc Clure Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
114
+0.47%
|
$24,168
$212.44 P/Share
|
|
Feb 05
2020
|
Domingo Miron Group Chief Executive-Fin Serv |
BUY
Grant, award, or other acquisition
|
Direct |
104
+0.19%
|
$22,048
$212.44 P/Share
|
|
Feb 05
2020
|
Jean Marc Ollagnier CEO EMEA |
BUY
Grant, award, or other acquisition
|
Direct |
1,045
+0.58%
|
$221,540
$212.44 P/Share
|
|
Feb 05
2020
|
David Rowland Executive Chairman |
SELL
Open market or private sale
|
Direct |
9,791
-8.19%
|
$2,075,692
$212.41 P/Share
|
|
Feb 05
2020
|
Ellyn Shook Chief Leadership & HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
114
+0.43%
|
$24,168
$212.44 P/Share
|
|
Feb 05
2020
|
Julie Spellman Sweet Chair and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
147
+1.18%
|
$31,164
$212.44 P/Share
|
|
Feb 05
2020
|
Joel Unruch General Counsel/Corp Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
94
+0.38%
|
$19,928
$212.44 P/Share
|
|
Feb 05
2020
|
John F Walsh Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
114
+0.56%
|
$24,168
$212.44 P/Share
|
|
Feb 03
2020
|
David Rowland Executive Chairman |
SELL
Open market or private sale
|
Direct |
5,814
-3.9%
|
$1,203,498
$207.14 P/Share
|
|
Feb 03
2020
|
Julie Spellman Sweet Chair and CEO |
SELL
Open market or private sale
|
Direct |
6,145
-8.84%
|
$1,272,015
$207.33 P/Share
|
|
Feb 01
2020
|
Jaime Ardila Director |
SELL
Payment of exercise price or tax liability
|
Direct |
543
-4.08%
|
$111,858
$206.81 P/Share
|
|
Feb 01
2020
|
Richard P Clark Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,565
-10.79%
|
$322,390
$206.81 P/Share
|
|
Feb 01
2020
|
Johan Deblaere Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,125
-3.27%
|
$437,750
$206.81 P/Share
|
|
Feb 01
2020
|
Simon Eaves Group Chief Executive-Products |
SELL
Payment of exercise price or tax liability
|
Direct |
165
-1.75%
|
$33,990
$206.81 P/Share
|
|
Feb 01
2020
|
James O Etheredge Chief Exec-North America |
SELL
Payment of exercise price or tax liability
|
Direct |
550
-3.67%
|
$113,300
$206.81 P/Share
|
|
Feb 01
2020
|
Herbert Hainer Director |
SELL
Payment of exercise price or tax liability
|
Direct |
986
-13.26%
|
$203,116
$206.81 P/Share
|
|
Feb 01
2020
|
Daniel T London Group Chief Exec - Health & PS |
SELL
Payment of exercise price or tax liability
|
Direct |
959
-4.1%
|
$197,554
$206.81 P/Share
|
|
Feb 01
2020
|
Kathleen R Mc Clure Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
739
-3.01%
|
$152,234
$206.81 P/Share
|
|
Feb 01
2020
|
Nancy Mc Kinstry Director |
SELL
Payment of exercise price or tax liability
|
Direct |
867
-15.44%
|
$178,602
$206.81 P/Share
|
|
Feb 01
2020
|
Domingo Miron Group Chief Executive-Fin Serv |
SELL
Payment of exercise price or tax liability
|
Direct |
417
-0.78%
|
$85,902
$206.81 P/Share
|
|
Feb 01
2020
|
Gilles Pelisson Director |
SELL
Payment of exercise price or tax liability
|
Direct |
986
-9.8%
|
$203,116
$206.81 P/Share
|
|
Feb 01
2020
|
Paula A Price Director |
SELL
Payment of exercise price or tax liability
|
Direct |
278
-3.3%
|
$57,268
$206.81 P/Share
|
|
Feb 01
2020
|
Venkata S M Renduchintala Director |
SELL
Payment of exercise price or tax liability
|
Direct |
458
-9.02%
|
$94,348
$206.81 P/Share
|
|
Feb 01
2020
|
David Rowland Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
6,737
-14.99%
|
$1,387,822
$206.81 P/Share
|
|
Feb 01
2020
|
Arun Sarin Director |
SELL
Payment of exercise price or tax liability
|
Direct |
330
-5.03%
|
$67,980
$206.81 P/Share
|
|
Feb 01
2020
|
Ellyn Shook Chief Leadership & HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,111
-4.1%
|
$228,866
$206.81 P/Share
|
|
Feb 01
2020
|
Julie Spellman Sweet Chair and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
575
-3.04%
|
$118,450
$206.81 P/Share
|
|
Feb 01
2020
|
Frank Kui Tang Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,353
-13.27%
|
$278,718
$206.81 P/Share
|
|
Feb 01
2020
|
Tracey Thomas Travis Director |
SELL
Payment of exercise price or tax liability
|
Direct |
376
-6.9%
|
$77,456
$206.81 P/Share
|
|
Feb 01
2020
|
John F Walsh Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
421
-2.05%
|
$86,726
$206.81 P/Share
|
|
Jan 30
2020
|
Jaime Ardila Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,062
+7.39%
|
-
|
|
Jan 30
2020
|
Herbert Hainer Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,641
+18.08%
|
-
|
|
Jan 30
2020
|
Nancy Mc Kinstry Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,062
+15.9%
|
-
|
|
Jan 30
2020
|
Gilles Pelisson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,798
+15.16%
|
-
|
|
Jan 30
2020
|
Paula A Price Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,714
+16.89%
|
-
|
|
Jan 30
2020
|
Venkata S M Renduchintala Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,617
+24.15%
|
-
|
|
Jan 30
2020
|
Arun Sarin Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,062
+13.93%
|
-
|
|
Jan 30
2020
|
Frank Kui Tang Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,593
+13.51%
|
-
|
|
Jan 30
2020
|
Tracey Thomas Travis Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,666
+23.42%
|
-
|
|
Jan 22
2020
|
Gianfranco Casati CEO-Growth Markets |
SELL
Open market or private sale
|
Direct |
5,000
-7.46%
|
$1,050,000
$210.74 P/Share
|
|
Jan 22
2020
|
Domingo Miron Group Chief Executive-Fin Serv |
SELL
Open market or private sale
|
Direct |
1,000
-0.92%
|
$210,000
$210.82 P/Share
|
|
Jan 22
2020
|
Ellyn Shook Chief Leadership & HR Officer |
SELL
Open market or private sale
|
Direct |
5,000
-8.09%
|
$1,050,000
$210.71 P/Share
|
|
Jan 22
2020
|
Kathleen R Mc Clure Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
833
-3.28%
|
$174,930
$210.25 P/Share
|
|
Jan 21
2020
|
Richard P Clark Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
3,533
-10.08%
|
$738,397
$209.38 P/Share
|
|
Jan 21
2020
|
Johan Deblaere Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,000
-1.48%
|
$627,000
$209.02 P/Share
|
|
Jan 21
2020
|
James O Etheredge Chief Exec-North America |
SELL
Open market or private sale
|
Direct |
6,347
-15.56%
|
$1,326,523
$209.4 P/Share
|
|
Jan 21
2020
|
Daniel T London Group Chief Exec - Health & PS |
SELL
Open market or private sale
|
Direct |
8,400
-9.36%
|
$1,747,200
$208.95 P/Share
|